The European market for dialysis access treatment devices is a dynamic market that will grow moderately through 2029, driven by the availability of novel and innovative products. However, market revenues will be hindered to some extent by declining ASPs resulting from pricing pressures, increasing competition and the impact of COVID-19 pandemic.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for dialysis access treatment products in Europe across a 10-year period.

The COVID-19 pandemic will cause a minimal decline in overall dialysis access procedures and revenues in 2020.

What factors will contribute to the decline in dialysis access treatment device market?

To what degree will the pandemic affect dialysis access creation and maintenance procedures?

How soon will procedure volumes, sales, and revenues recover over the forecast period?

Premium-priced devices will see increased adoption in the dialysis access treatment device market.

What factors will drive this adoption?

Which devices and companies will benefit the most from this shift?

Clinical data and treatment guidelines will drive shifts in device preferences.

What clinical trials and clinical studies have been performed in the dialysis access treatment device space?

What will be the impact of these clinical trials be on device adoption trends?

New technologies like percutaneous AVF catheters will disrupt the dialysis access creation market.

What is the market forecast for percutaneous AVF catheters?

How will the availability of percutaneous AVF catheters affect surgical AVF procedures and the use of AVGs and dialysis catheters?

Table of contents

  • Dialysis Access Treatment Devices - Market Insights - Europe

Author(s): Bishwjit Ghoshal, MBA

Bishwjit Ghoshal is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.

Follow Bishwjit on twitter: @Bishwjit_DRG